Upgrade of permanent pacemakers and single chamber implantable cardioverter defibrillators to pectoral dual chamber implantable cardioverter defibrillators: Indications, surgical approach, and long-term clinical results

PACE - Pacing and Clinical Electrophysiology

Volumn 25, Issue 12, 2002, Pages 1715-1723

  Sweeney, Michael O ^a   Shea, Julie B ^a   Ellison, Kristin E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

LCDs; Pacemaker; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL FEATURE; CONTROLLED STUDY; DEFIBRILLATOR; ELECTRIC CONDUCTIVITY; ELECTRIC POTENTIAL; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HUMAN; ISCHEMIC HEART DISEASE; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALE; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0036915687     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2002.01715.x     Document Type: Article

References (47)

1. Brode SE, Schwartzman D, Callans DJ, et al. ICD-antiarrhythmic drug and ICD-pacemaker interactions. J Cardiovasc Electrophysiol 1997; 8:830-842.
2. Blanck Z, Niazi I, Axtell K, et al. Feasibility of concomitant implantation of permanent transvenous pacemaker and defibrillator systems. Am J Cardiol 1994; 74:1249-1253.
3. Brooks R, Garan H, McGovern BA, et al. Implantation of transvenous nonthoracotomy cardioverter-defibrillator systems in patients with permanent endocardial pacemakers. Am Heart J 1995; 129:45-53.
4. Iskos D, Fahy GJ, Lurie KG, et al. Physiologic cardiac pacing in patients with contemporary implantable cardioverter-defibrillators. Am J Cardiol 1998; 82:66-71.
5. Geiger MJ, O'Neill P, Sharma A, et al. Interactions between transvenous nonthoracotomy cardioverter defibrillator systems and permanent transvenous endocardial pacemakers. PACE 1997; 20:624-630.
6. Glikson M, Trusty JM, Grice SK, et al. Importance of pacemaker noise reversion as a potential mechanism of pacemaker-ICD interactions. PACE 1998; 21:1111-1121.
7. Jones GK, Bardy GH. Implanation of ICDs in the electrophysiology laboratory. In I Singer, (ed.): Interventional Electrophysiology. Baltimore, Williams and Wilkins, 1997, pp. 725-740.
8. Byrd CL. Management of implant complications. In KA Ellenbogen, GN K, BL Kay Wilkoff (eds.): Clinical Cardiac Pacing. Philadelphia, W.B. Saunders Company, 1995, pp. 491-522.
9. Fotuhi PC, KenKnight BH, Melnick SB, et al. Effect of a passive endocardial electrode on defibrillation efficacy of a nonthoracotomy lead system. J Am Coll Cardiol 1997; 29:825-830.
10. Jarwe M, Messaoudene SA, Klug D, et al. Predictors of thrombosis after transvenous permanent pacemaker implantation. (abstract) Circulation 2000; 102:II-787.
11. Sticherling C, Chough SP, Baker RL, et al. Prevalence of central venous occlusion in patients with chronic implantable defibrillator leads. Am Heart J 2001: 141:813-816.
12. Byrd CL, Schwartz SJ, Hedin NB, et al. Intravascular lead extraction using locking stylets and sheaths. PACE 1990; 13:1871-1875.
13. Epstein LM, Byrd CL, Wilkoff BL, et al. Initial experience with larger laser sheaths for the removal of transvenous pacemaker and implantable defibrillator leads. Circulation 1999; 100:516-525.
14. Ong LS, Barold SS, Lederman M, et al. Cephalic vein guide wire technique for implantation of permanent pacemakers. Am Heart J 1987; 114:753-756.
15. Magney JE, Staplin DH, Flynn DM, et al. A new approach to percutaneous subclavian venipuncture to avoid lead fracture or central venous catheter occlusion. PACE 1993; 16:2133-2142.
16. Kim SG, Fogoros RN, Furman S, et al. Standardized reporting of ICD patient outcome: The report of a North American Society of Pacing and Electrophysiology Policy Conference, February 9-10, 1993. PACE 1993; 16:1358-1362.
17. Knight BP, Strickberger SA, Daoud E, et al. Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol 1999; 33:1970-1974.
18. Maron BJ, Shen WK, Link M, et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000; 342:365-373.
19. Lamas GA, Lee KL, Sweeney MO, et al., For the MOST Investigators. Clinical events and quality of life in a randomized trial of ventricular as compared with dual chamber pacing in patients with sinus node dysfunction. Proceedings of the North American Society of Pacing 22nd Annual Scientific Sessions, Late Breaking Clinical Trials, Boston, MA, 2001.
20. Michaud G, Pelosi F Jr, Noble MD, et al. A randomized trial comparing heparin initiation 6h or 24h after pacemaker or defibrillator implantation. J Am Coll Cardiol 2000; 35:1915-1918.
21. Epstein AE, Kay GN, Plumb VJ, et al. Elevated defibrillation threshold when right-sided venous access is used for nonthoracotomy implantable defibrillator lead implantation. The Endotak Investigators. J Cardiovasc Electrophysiol 1995; 6:979-986.
22. Kirk MM, Shorofsky SR, Gold MR. Right sided active pectoral pulse generators do not reduce defibrillation thresholds. (abstract) PACE 1999; 22:747.
23. Fotuhi PC, Ideker RE, Idriss SF, et al. Influence of epicardial patches on defibrillafion threshold with nonthoracotomy lead configurations. Circulation 1995; 92:3082-3088.
24. Callihan RL, Idriss SF, Dahl RW, et al. Comparison of defibrillation probability of success curves for an endocardial lead configuration with and without an inactive epicardial patch. J Am Coll Cardiol 1995; 25:1373-1379.
25. Sweeney MO, Ellison KE, Shea JB. Provoked and spontaneous high frequency, low amplitude respirophasic noise transients in patients with implantable cardioverter-defibrillators. J Cardiovasc Electrophysiol 2001; 12:402-410.
26. Williamson B, Baker JH, Bartelt NJ, et al. Atrial lead position affects far-field R wave oversensing for rate responsive dual chamber implantable cardioverter defibrillators. (abstract) PACE 1999; 22:849.
27. Frohlig G, Iewani Z, Kusch O, et al. Bipolar ventricular far-field signals in the atrium. PACE 1999; 22:1604-1613.
28. Frohlig G, Kinderman M, Heisel A, et al. Mode switch without atrial tachyarrhythmias. (abstract) PACE 1996; 19:592.
29. Glikson M, Trusty JM, Grice SK, et al. A stepwise testing protocol for modern implantable cardioverter defibrillator systems to prevent pacemaker-implantable cardioverter-defibrillator interactions. Am J Cardiol 1999; 83:360-366.
30. Lee ME, Chaux A. Unusual complications of endocardial pacing. J Thorac Cardiovasc Surg 1980; 80:934-940.
31. Brandt J, Fahraeus T, Schuller H. Far-field QRS complex sensing via the atrial pacemaker lead. I. Mechanism, consequences, differential diagnosis and countermeasures in AAI and VDD/DDD pacing. PACE 1988; 11:1432-1438.
32. Brandt J, Fahraeus T, Schuller H. Far-field QRS complex sensing via the atrial pacemaker lead. II. Prevalence, clinical significance and possibility of intraoperative prediction in DDD pacing. PACE 1988; 11:1540-1544.
33. Brandt J, Worzewski W. Far-field QRS complex sensing: Prevalence and timing with bipolar atrial leads. PACE 2000; 23:315-320.
34. Weretka S, Becker R, Hilbel T, et al. Far-field R wave oversensing in new dual chamber ICDs. Incidence, predisposing factors and clinical implications. (abstract) PACE 2000; 23:571.
35. Timmis GC, Westveer DC, Gadowski G, et al. The effect of electrode position on atrial sensing for physiologically responsive cardiac pacemakers. PACE 1984; 108:909-916.
36. Kantharia B, wilbur S, Padder F, et al. Effect of different location of the atrial lead on the nearfield and farfield electrograms in dual chamber pacemaker-defibrillators. (abstract) PACE 1999; 22:824.
37. DeCaprio V, Hurzeler P, Furman S. A comparison of unipolar and bipolar electrograms for cardiac pacemaker sensing. Circulation 1977; 56:750-755.
38. Dijkman B, Wellens HJJ. Importance of far field R wave sensing evaluation for correct function of arrhythmia discrimination algorithm in dual chamber ICD. (abstract) PACE 2000; 23:676.
39. Lickfett L, Wolpert L, Jung W, et al. Inappropriate implantable defibrillator discharge caused by a retained pacemaker lead fragment. J Interv Card Electrophysiol 1999; 3:163-167.
40. Vaughan T, Medtronic Inc. Oversensing Due to Mechanical Contact with an ICD Sensing Coil. (Personal communication).
41. Geelen P, Lorga-Filho A, Chauvin M, et al. The value of DDD pacing in patients with an implantable cardioverter defibrillator. PACE 1997; 20:177-181.
42. Higgins SL, Williams SK, Pak JP, et al. Indications for implantation of a dual-chamber pacemaker combined with an implantable cardioverter-defibrillator. Am J Cardiol 1998; 81:1360-1362.
43. Sutandar A, Solimon S, Kaddaha R, et al. Should all patients receive a dual chamber device? Unanticipated use of the implantable defibrillator as a pacemaker. J Am Coll Cardiol 2000; 35:127A.
44. Andersen HR, Nielsen JC, Rhomsen PEB, et al. Long-term follow-up of patients from a randomized trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997; 350:1210-1216.
45. Connolly SJ, Kerr CR, Gent M, et al., For the Canadian Trial of Physiologic Pacing Investigators. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N Engl J Med 2000; 342:1385-1391.
46. Grimm W, Flores BT, Marchlinski FE. Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators. PACE 1992; 15:1667-1673.
47. Kuhlkamp V, Dornberger V, Mewis C, et al. Clinical experience with the new detection algorithms for atrial fibrillation of a defibrillator with dual chamber sensing and pacing. J Cardiovasc Electrophysiol 1999; 10:905-915.